Boston Scientific has seen its share price fall sharply over the past year, which naturally raises a question for investors ...

Boston Scientific is a leading medical technology company produces high-performance solutions that address patient needs. Read why BSX stock is a strong buy.

By Sahil Pandey Aug 26 (Reuters) - Boston Scientific said on Wednesday that a cybersecurity incident had disrupted global operations, including some information systems used to process and ship ...

The attack has disrupted the company's ability to ship products, and it's not clear when services will be restored.

On September 17, 2026, Citigroup downgraded their outlook for Boston Scientific (BIT:1BSX) from Buy to Neutral. This rating action follows a prior action on July 30, 2026, when Citigroup maintained ...

Boston Scientific Corporation (NYSE:BSX) fell 2.3% in early trading on September 8, 2026, after disclosing that an August 25 ...

Boston Scientific warns that the cyberattack will hit Q3, but recovery may delay—not lose—revenue. Click here to read this ...

The medical device specialist was the victim of a cyberattack.

On Aug. 26, 2026, a cyberattack halted order processing and shipping at the medical device maker, leaving investors uncertain about the speed of recovery and near-term shipment delays.

Boston Scientific said it likely won’t meet its financial guidance due to the cyberattack that has disrupted its operations, ...

Boston Scientific said on Tuesday it no longer expects to meet ​its previously issued third-quarter and full-year 2026 sales ...

Citi said uncertainty surrounds Boston Scientific’s immediate future as headwinds are complicated by its recovery from a major cyberattack.